Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi’s Sarcoma Patients in South Africa
Viruses · 2024
DOI: 10.3390/v16020189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Rebecca Monica Tibenderana und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, University of Cape Town, Cape Town 7925, South Africa. Hauptthemen laut MEDLINE: Sarcoma, Kaposi, Herpesvirus 8, Human, HIV Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European & Developing Countries Clinical Trials Partnership, AIDS and Cancer Specimen Resource, National Research Foundation.
Abstract (Originalsprache)
Kaposi’s sarcoma (KS) is an AIDS-defining illness caused by Kaposi’s sarcoma-associated herpesvirus (KSHV) predominantly in the context of HIV-related immune suppression. We aimed to explore the usefulness of KSHV DNA viral load (VL) measurement in predicting the severity, response to treatment and outcome of KS. We retrospectively assessed a cohort of KS patients (n = 94) receiving treatment at Groote Schuur Hospital, Cape Town, South Africa. Demographic and clinical data, KS staging and response to treatment were extracted from patient files, while long-term survival was ascertained from hospital records. KSHV serology and VL and hIL-6 were determined empirically from patients’ blood. All patients were HIV-positive adults, the majority of whom were on HAART at the time of recruitment. KSHV VL was detectable in 65 patients’ blood (median: 280.5/106 cells (IQR: 69.7–1727.3)) and was highest in patients with S1 HIV-related systemic disease (median 1066.9/106 cells, IQR: 70.5–11,269.6). KSHV VL was associated with the S1 stage in a binomial regression controlling for confounders (adjusted odds ratio 5.55, 95% CI: 1.28–24.14, p = 0.022). A subset of six patients identified to have extremely high KSHV VLs was predominantly T1 stage with pulmonary KS, and most had died at follow-up. In our cohort, elevated KSHV VL is associated with systemic HIV-related illness in KS disease. Extremely high KSHV VLs warrant further investigation for patients potentially requiring intensive treatment and investigation for progression or diagnosis of concurrent KSHV lytic syndromes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, University of Cape Town, Cape Town 7925, South Africa.
- Department of Integrative Biomedical Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa.
- International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town 7925, South Africa.
- Aberdeen Surgery, Aberdeen, NSW 2336, Australia.
- Hatchile Consult Ltd., Kampala 759125, Uganda.
ORCID-Profile: Melissa Jayne Blumenthal, Georgia Schäfer, Zainab Mohamed
Förderung
- European & Developing Countries Clinical Trials Partnership
- AIDS and Cancer Specimen Resource
- National Research Foundation
- South African Medical Research Council
- Poliomyelitis Research Foundation
- EDCTP2 programme
- NRF
- MRC
Zitieren
APA
Tibenderana, R. M., Blumenthal, M. J., Bukajumbe, E., Schäfer, G., & Mohamed, Z. (2024). Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi’s Sarcoma Patients in South Africa. Viruses. https://doi.org/10.3390/v16020189
Vancouver
Tibenderana RM, Blumenthal MJ, Bukajumbe E, Schäfer G, Mohamed Z. Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi’s Sarcoma Patients in South Africa. Viruses. 2024. doi:10.3390/v16020189
BibTeX
@article{Tibenderana2024,
author = {Tibenderana, Rebecca Monica and Blumenthal, Melissa Jayne and Bukajumbe, Emmanuel and Schäfer, Georgia and Mohamed, Zainab},
title = {Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi’s Sarcoma Patients in South Africa},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16020189}
}
EUVIMED